The association of fetuin-A with cardiovascular disease mortality in older community-dwelling adults: the Rancho Bernardo study.

Journal of the American College of Cardiology
Gail A LaughlinJoachim H Ix

Abstract

The goal of this study was to evaluate the prospective association of fetuin-A levels with cardiovascular disease (CVD) mortality. Fetuin-A is a circulating inhibitor of calcium deposition in the vasculature and of insulin action in muscle and fat, and may be involved in the pathogenesis of CVD. This is a population-based prospective study of 633 men and 1,025 women (median age = 73 years) who had fetuin-A levels and CVD risk factors evaluated in 1992 to 1996 and were followed for vital status through 2010. Plasma fetuin-A (g/l ± SD) was highest in women using oral estrogens (0.55 ± 0.12), intermediate for women not using oral estrogens (0.51 ± 0.10), and lowest for men (0.50 ± 0.10), p < 0.001. Lower fetuin-A levels were associated with older age, but with lower levels of other CVD risk factors including adiposity, blood pressure, lipids, triglycerides, and insulin resistance (all p < 0.01). During the median 12-year follow-up, 273 deaths were attributed to CVD. The association of fetuin-A with CVD mortality differed by diabetes status (p for interaction = 0.003). Adjusting for age, sex, oral estrogens, and lifestyle, the hazard ratio for CVD mortality comparing the lowest fetuin-A quartile with all higher values was 1.76 (95%...Continue Reading

References

May 19, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Angela Yee-Moon WangJohn E Sanderson
Apr 19, 2006·Hypertension·Markus KettelerJürgen Floege
Apr 29, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Joachim H IxMary A Whooley
Jul 5, 2006·International Journal of Obesity : Journal of the International Association for the Study of Obesity·G A LaughlinS May
Feb 6, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·UNKNOWN KDOQI
Mar 8, 2007·Kidney International·M M H HermansUNKNOWN Netherlands cooperative study on the adequacy of Dialysis (NECOSAD)
Jul 10, 2008·JAMA : the Journal of the American Medical Association·Joachim H IxUNKNOWN Health ABC Study
Jul 18, 2008·Diabetes·Norbert StefanMatthias B Schulze
Nov 26, 2008·Circulation·Cornelia WeikertAndreas Fritsche
Jun 11, 2011·Circulation Research·Willi Jahnen-DechentMarkus Ketteler

❮ Previous
Next ❯

Citations

Oct 5, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Cesare Cuspidi, Carla Sala
Feb 6, 2013·Epidemiologic Reviews·Peter M EngelfrietMartijn E T Dollé
Jun 13, 2014·International Journal of Nanomedicine·Larry W HunterVirginia M Miller
Dec 12, 2013·Clinical Endocrinology·Gail A LaughlinJoachim H Ix
Sep 16, 2015·Current Diabetes Reports·Leah E CahillMajken K Jensen
Feb 16, 2013·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Zi-Wen ZhaoHong Zheng
May 20, 2015·BoneKEy Reports·Michael M X CaiStephen G Holt
Dec 4, 2014·International Journal of Obesity : Journal of the International Association for the Study of Obesity·J F TrepanowskiK A Varady
Mar 17, 2015·Journal of Diabetes and Its Complications·Fatih AkinCem Sahin
Apr 29, 2015·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Anna Maria DabrowskaDariusz Duma
Oct 19, 2013·Medical Oncology·Lianjie LinChangqing Zheng
Jan 8, 2016·Biochimie·Katie N Robinson, Margarita Teran-Garcia
Jun 26, 2014·Journal of the American Heart Association·Qi SunKathryn M Rexrode
Sep 16, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Xuechen ChenWenhua Ling
Mar 3, 2015·Diabetes & Metabolism Journal·Hye Jin Yoo, Kyung Mook Choi
Jan 1, 2014·Orvosi hetilap·Krisztián VörösLászló Kalabay
Jan 25, 2014·Clinical Journal of the American Society of Nephrology : CJASN·Julia J SciallaRulan S Parekh
Nov 14, 2019·Current Pharmaceutical Design·Caterina M GambinoMarcello Ciaccio
Oct 31, 2013·Clinical Chemistry·Monik C JiménezKathryn M Rexrode
Jun 27, 2020·Dermatologic Therapy·Abdullah DemirbaŞGözde UlutaŞ DemirbaŞ
Feb 14, 2015·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Fatih AkinMehmet Kanbay
Nov 27, 2019·Journal of Clinical Medicine·Lynda Bourebaba, Krzysztof Marycz
May 12, 2015·The American Journal of Cardiology·Alice LiuGerald M Reaven
Feb 23, 2019·Journal of Gynecology Obstetrics and Human Reproduction·Miguel AlbuquerquePierre-François Ceccaldi
Jul 3, 2021·International Journal of Molecular Sciences·Teoman DogruAlper Sonmez

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.